|
The congress
Content and speakers to attract your customers
This conference is where the ideas, intelligence and relationships develop the business models of the future.
The increasing demand for high volume products, in addition to advances in fermentation and cell culture is driving a paradigm shift in biopharmaceutical process scale-up. The development phase of biological products is knowingly slow, expensive and complicated, often leading to bottlenecks in getting new products from the lab to the clinic. As speed is critical, the paradigm shift is needed to address the shortfall in new tools and methods allowing accelerated biopharmaceutical development.
This congress will address the design decisions currently being thought through and implemented, demonstrating the strategic impact of different process design and scale-up routes taken by pharma and biotech companies alike.
Focussing on the strategies that are becoming increasingly important to improving bioprocessing efficiency, the congress will identify with a systems based understanding of biology for improved bioprocessing scale-up that will lead to increased predictability of biological processes for improved scale-up, improved cost efficiency, increased speed to clinic and market and the tools and methodologies for enhancing bioprocessing scale-up.
The conference features:
- A visionary keynote presentation
- Presentations from industry leaders
- A case study based program that ensures quality information
- A masterclass workshop program
European Biopharm Scale-up Congress is the place where strategy, know-how and ideas come together.
Senior sponsors will have the opportunity to shape this leading conference agenda and to influence industry direction. Sponsor packages will be allocated on a first come basis.
The conference will cover:
- Biopharmaceutical scale up as a competitive advantage
- Time of cost to market
- Purification and extraction
- Speed to market
- Regulatory implications
- The need to reserve capacity
- Scaling-up in the face of a pandemic
- New technologies and developments
- Improving manufacturing timelines
- Process optimisation
- The challenge of meeting speed and quality
|
